Ustekinumab
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Ustekinumab is used to treat psoriatic arthritis, ulcerative colitis, crohn disease and psoriasis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $3.4 billion on Ustekinumab across 133,000 claims for 25,000 beneficiaries.
Ustekinumab is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $29792.79 to $29874.45 per ML — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$29792.79 – $29874.45
per ML
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Janssen Biotech, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Interleukin-23 Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing USTEKINUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
STELARA 45 MG/0.5 ML SYRINGE | $29874.4480 per ML | — |
STELARA 90 MG/ML SYRINGE | $29792.7867 per ML | — |
Frequently Asked Questions
What is Ustekinumab used to treat?
Ustekinumab is used to treat psoriatic arthritis, ulcerative colitis, crohn disease and psoriasis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Ustekinumab?
In 2024, Medicare Part D spent $3.4 billion on Ustekinumab across 133,000 claims for 25,000 beneficiaries.
How many Ustekinumab products are on the market?
The Ustekinumab drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Ustekinumab?
NADAC reference prices for Ustekinumab range from $29792.7867 to $29874.4480 per ML — a 0% difference between cheapest and most expensive.
Which manufacturers make Ustekinumab?
1 manufacturer lists Ustekinumab in NADAC. Ranked by number of NDCs, the largest are Janssen Biotech, Inc. (2).